Recently Viewed
Clear AllToday’s Range
52 Week Range
Liquidity
Market cap
₹78 Cr
Revenue (TTM)
₹45 Cr
Net Profit (TTM)
₹2 Cr
ROE
6.6 %
ROCE
9.5 %
P/E Ratio
42
P/B Ratio
3.1
Industry P/E
15.77
EV/EBITDA
8.7
Div. Yield
0 %
Debt to Equity
1.2
Book Value
₹35.6
EPS
₹2.3
Face value
10
Shares outstanding
6,965,263
CFO
₹74.66 Cr
EBITDA
₹71.17 Cr
Net Profit
₹4.12 Cr
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Choksi Lab
| -13.4 | 0.8 | -16.3 | -15.4 | 49.8 | 68.0 | 25.4 |
|
*
| -- | -- | -- | -- | -- | -- | -- |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|---|
|
Choksi Lab
| 43.4 | 4.4 | 60.6 | 94.3 | 138.2 | -6.8 | -39.7 |
|
BSE Small Cap
| -6.6 | 29.0 | 47.5 | -1.8 | 62.8 | 32.1 | -6.8 |
|
| -1.3 | 28.1 | 69.3 | 19.6 | 66.6 | 17.8 | -7.8 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Choksi Lab
|
111.9 | 77.9 | 44.6 | 1.9 | 11.5 | 6.6 | 42 | 3.1 |
| 62.7 | 73.3 | 249.1 | 8.0 | 4.6 | 10.8 | 9.2 | 0.9 | |
| 45.7 | 679.5 | 3,318.7 | -50.1 | 0.3 | -1.4 | -- | 1.0 | |
| 267.5 | 1,851.8 | 1,066.8 | 81.0 | 13.1 | 10.3 | 22.9 | 2.2 | |
| 878.2 | 2,458.7 | 1,192.5 | -60.7 | 1.6 | -- | -- | 2.2 | |
| 1,405.2 | 10,364.9 | 4,129.6 | 381.4 | 9.2 | 17.6 | 27.1 | 4.4 | |
| 9.9 | 2,326.7 | 333.2 | 99.3 | 20.1 | -- | 90.7 | 0.7 | |
| 170.7 | 2,389.3 | 850.2 | 53.6 | 8.2 | 12.8 | 44.9 | 4.9 | |
| 100.4 | 212.3 | 215.3 | 13.7 | 9.9 | 11.7 | 15.8 | 1.4 | |
| 37.7 | 497.7 | 64.3 | 41.7 | 87.2 | 4.8 | 11.9 | 0.8 |
No Review & Analysis are available.
Choksi Laboratories Limited provides contract testing and analytical services in India and internationally. The company's contract laboratory services include pharmaceutical, food and beverages, water, and construction material analysis. Its... instrument calibration and validation services comprise laboratory and on-site calibration for test equipment, process equipment, and various end-user equipment; plant shutdown calibration; and consultancy for setting up an in-house calibration laboratory. The company also offers environment management, laboratory, waste water management, and air pollution monitoring services. In addition, it provides clinical research services, such as bio-availability and bio-equivalence studies; and consultancy and allied services consisting of training, third-party inspection, auditing, laboratory set-up and management, and environment management services. Further, the company offers assaying and hallmarking services for gold and silver. It primarily serves the pharmaceuticals, consumer products, and engineering sectors. The company was founded in 1982 and is based in Indore, India. Read more
Incorporated
1993
Chairman
Sunil Choksi
Managing Director
Sunil Choksi
Headquarters
Indore, Madhya Pradesh
Website
Annual Reports
The share price of Choksi Laboratories Ltd is ₹111.85 (BSE) as of 20-Mar-2026 IST. Choksi Laboratories Ltd has given a return of 49.76% in the last 3 years.
The P/E ratio of Choksi Laboratories Ltd is 41.95 times as on 20-Mar-2026, a 166 premium to its peers’ median range of 15.77 times.
The P/B ratio of Choksi Laboratories Ltd is 3.14 times as on 20-Mar-2026, a 131 premium to its peers’ median range of 1.36 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
54.94
|
3.55
|
|
2024
|
26.60
|
1.33
|
|
2023
|
7.26
|
1.10
|
|
2022
|
85.46
|
0.99
|
|
2021
|
-2.11
|
0.31
|
The 52-week high and low of Choksi Laboratories Ltd are Rs 236.70 and Rs 81.85 as of 21-Mar-2026.
Choksi Laboratories Ltd has a market capitalisation of ₹ 78 Cr as on 20-Mar-2026. As per SEBI classification, it is a Small Cap company.
Before investing in Choksi Laboratories Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.